Published in Otolaryngol Head Neck Surg on February 04, 2011
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J Clin Invest (2013) 1.89
Barriers to oral cancer screening: a focus group study of rural Black American adults. Psychooncology (2012) 1.05
What are our AIMs? Interdisciplinary Perspectives on the Use of Ancestry Estimation in Disease Research. AJOB Prim Res (2012) 0.79
Molecular characterization of head and neck cancer: how close to personalized targeted therapy? Mol Diagn Ther (2012) 0.78
Identifying the risk factors for late-stage head and neck cancer. Expert Rev Anticancer Ther (2011) 0.77
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics (2003) 53.11
Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71
Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med (2010) 22.74
Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst (2000) 14.43
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst (2003) 7.06
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol (2006) 4.66
Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum Mutat (2009) 4.65
Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst (2007) 4.55
A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping. Am J Hum Genet (2006) 3.77
Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila) (2009) 3.70
Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer (2008) 2.67
Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Res (2007) 2.53
Ethnic-difference markers for use in mapping by admixture linkage disequilibrium. Am J Hum Genet (2002) 2.29
A causal role for human papillomavirus in head and neck cancer. Lancet (2004) 2.21
The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg (1998) 1.96
Race, ancestry, and genes: implications for defining disease risk. Annu Rev Genomics Hum Genet (2003) 1.81
Markers informative for ancestry demonstrate consistent megabase-length linkage disequilibrium in the African American population. Hum Genet (2003) 1.80
Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg (2001) 1.71
Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study. Cancer (2003) 1.41
Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol (2007) 1.41
Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men. Cancer Prev Res (Phila) (2009) 1.36
Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev (2003) 1.34
Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans. Prostate (2010) 1.32
Genetic heterogeneity in colorectal cancer associations between African and European americans. Gastroenterology (2010) 1.31
Genome-wide linkage and admixture mapping of type 2 diabetes in African American families from the American Diabetes Association GENNID (Genetics of NIDDM) Study Cohort. Diabetes (2008) 1.27
Admixture mapping as a tool in gene discovery. Curr Opin Genet Dev (2007) 1.23
Putative ancestral origins of chromosomal segments in individual african americans: implications for admixture mapping. Genome Res (2004) 1.18
Conceptualizing human variation. Nat Genet (2004) 1.13
Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer. Carcinogenesis (2009) 1.13
Novel single nucleotide polymorphism associations with colorectal cancer on chromosome 8q24 in African and European Americans. Carcinogenesis (2009) 1.08
Patient and tumor factors at diagnosis in a multi-ethnic primary head and neck squamous cell carcinoma cohort. J Surg Oncol (2009) 0.93
The relationship between "race" and genetics in biomedical research. Curr Hypertens Rep (2007) 0.92
Comparison of statistical methods for estimating genetic admixture in a lung cancer study of African Americans and Latinos. Am J Epidemiol (2008) 0.89
Simple predictors of survival in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2002) 0.85
The race for ancestral genetics in clinical trials. J Natl Cancer Inst (2006) 0.77
Control of confounding of genetic associations in stratified populations. Am J Hum Genet (2003) 7.99
Skin pigmentation, biogeographical ancestry and admixture mapping. Hum Genet (2003) 4.67
Large-scale SNP analysis reveals clustered and continuous patterns of human genetic variation. Hum Genomics (2005) 3.77
cis-Regulatory changes in Kit ligand expression and parallel evolution of pigmentation in sticklebacks and humans. Cell (2007) 3.72
Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care (2004) 3.31
The landscape of recombination in African Americans. Nature (2011) 3.06
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study. J Clin Oncol (2006) 2.87
Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet (2011) 2.70
Genetic evidence for the convergent evolution of light skin in Europeans and East Asians. Mol Biol Evol (2006) 2.54
Genetic ancestry and the search for personalized genetic histories. Nat Rev Genet (2004) 2.08
The 8818G allele of the agouti signaling protein (ASIP) gene is ancestral and is associated with darker skin color in African Americans. Hum Genet (2005) 1.97
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J Clin Invest (2013) 1.89
Patient-physician colorectal cancer screening discussions and screening use. Am J Prev Med (2006) 1.87
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y. J Clin Invest (2006) 1.79
Improving asthma care through recertification: a cluster randomized trial. Arch Intern Med (2007) 1.54
Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. PLoS Genet (2011) 1.54
Human genetic diversity and the nonexistence of biological races. Hum Biol (2003) 1.53
Human genetic diversity and the nonexistence of biological races. 2003. Hum Biol (2009) 1.51
Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry. PLoS Genet (2011) 1.47
Allelic variation at alcohol metabolism genes ( ADH1B, ADH1C, ALDH2) and alcohol dependence in an American Indian population. Hum Genet (2003) 1.39
Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab (2010) 1.36
Reducing the health risks of diabetes: how self-determination theory may help improve medication adherence and quality of life. Diabetes Educ (2009) 1.36
Inconsistencies in patient perceptions and observer ratings of shared decision making: the case of colorectal cancer screening. Patient Educ Couns (2010) 1.35
Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans. Prostate (2010) 1.32
Genetic heterogeneity in colorectal cancer associations between African and European americans. Gastroenterology (2010) 1.31
COX-2 gene promoter haplotypes and prostate cancer risk. Carcinogenesis (2004) 1.30
Colorectal carcinoma screening procedure use among primary care patients. Cancer (2005) 1.29
IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans. Carcinogenesis (2007) 1.28
Markers that discriminate between European and African ancestry show limited variation within Africa. Hum Genet (2002) 1.27
Factors contributing to the racial differences in prostate cancer mortality. BJU Int (2005) 1.26
Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study). Circulation (2010) 1.22
Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. J Nutr (2002) 1.19
Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis. Pharmacoepidemiol Drug Saf (2009) 1.18
Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Mol Cancer Ther (2004) 1.16
Peak aerobic capacity predicts prognosis in patients with coronary heart disease. Am Heart J (2008) 1.15
Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer. PLoS One (2012) 1.15
Prioritization of evidence-based preventive health services during periodic health examinations. Am J Prev Med (2012) 1.14
Adherence analysis using visual analog scale versus claims-based estimation. Ann Pharmacother (2007) 1.12
Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/dystonia in the jittery mouse. Nat Genet (2003) 1.12
Results from a prostate cancer admixture mapping study in African-American men. Hum Genet (2009) 1.11
Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic-Americans and African-Americans. Pharmacogenomics (2012) 1.09
Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans. Pharmacogenet Genomics (2015) 1.08
Novel single nucleotide polymorphism associations with colorectal cancer on chromosome 8q24 in African and European Americans. Carcinogenesis (2009) 1.08
African ancestry is associated with asthma risk in African Americans. PLoS One (2012) 1.07
Genotype-guided dosing of vitamin K antagonists. N Engl J Med (2014) 1.06
Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy). Urology (2006) 1.05
Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol (2004) 1.04
Adjusting for population structure in admixed populations. Genet Epidemiol (2002) 1.04
Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer (2008) 1.03
Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk. Prostate (2010) 1.02
The economic impact of false-positive cancer screens. Cancer Epidemiol Biomarkers Prev (2004) 1.01
ICAM gene cluster SNPs and prostate cancer risk in African Americans. Hum Genet (2006) 0.99
8q24 risk alleles in West African and Caribbean men. Prostate (2012) 0.98
E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters. Am J Clin Pathol (2006) 0.97
Aromatherapy as treatment for postoperative nausea: a randomized trial. Anesth Analg (2012) 0.97
8q24 sequence variants in relation to prostate cancer risk among men of African descent: a case-control study. BMC Cancer (2010) 0.97
Patient-physician colorectal cancer screening discussions: delivery of the 5A's in practice. Am J Prev Med (2011) 0.97
Predictors of serum vitamin D levels in African American and European American men in Chicago. Am J Mens Health (2012) 0.96
Generalizability of established prostate cancer risk variants in men of African ancestry. Int J Cancer (2014) 0.96
Patient-rated importance and receipt of information for colorectal cancer screening. Cancer Epidemiol Biomarkers Prev (2011) 0.95
Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer. Urology (2009) 0.95
Protective effect of diabetes against metastasis in patients with non-small cell lung cancer. Arch Intern Med (2007) 0.94
Type 2 deiodinase and host responses of sepsis and acute lung injury. Am J Respir Cell Mol Biol (2011) 0.94
Colorectal cancer screening use among insured primary care patients. Am J Manag Care (2011) 0.93
Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among men of African descent: a case-control study. BMC Cancer (2009) 0.93
No association between variant DNA repair genes and prostate cancer risk among men of African descent. Prostate (2010) 0.92
The relationship between "race" and genetics in biomedical research. Curr Hypertens Rep (2007) 0.92
Are there race/ethnicity differences in outpatient congestive heart failure management, hospital use, and mortality among an insured population? Med Care (2004) 0.91
Genome-wide linkage of 77 families from the African American Hereditary Prostate Cancer study (AAHPC). Prostate (2007) 0.91
Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases. Prostate (2008) 0.91
Improved survival with HPV among African Americans with oropharyngeal cancer. Clin Cancer Res (2013) 0.90
Comparison of statistical methods for estimating genetic admixture in a lung cancer study of African Americans and Latinos. Am J Epidemiol (2008) 0.89
Prostate cancer susceptibility Loci identified on chromosome 12 in African Americans. PLoS One (2011) 0.89
Acute pancreatitis in patients on chronic peritoneal dialysis: an increased risk? Am J Gastroenterol (2005) 0.89
Contribution of higher risk genes and European admixture to Crohn's disease in African Americans. Inflamm Bowel Dis (2012) 0.88
Common vitamin D pathway gene variants reveal contrasting effects on serum vitamin D levels in African Americans and European Americans. Hum Genet (2014) 0.88
Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans. Cancer Causes Control (2014) 0.87
Significance of p16 in Site-specific HPV Positive and HPV Negative Head and Neck Squamous Cell Carcinoma. Cancer Clin Oncol (2013) 0.87
Smoking and prostate cancer in a multi-ethnic cohort. Prostate (2013) 0.87
A comparison of smokers' and nonsmokers' fruit and vegetable intake and relevant psychosocial factors. Behav Med (2009) 0.87
Racial disparities in prostate cancer incidence, biochemical recurrence, and mortality. Prostate Cancer (2011) 0.87
Regional differences in awareness and attitudes regarding genetic testing for disease risk and ancestry. Hum Genet (2010) 0.87
E-cadherin polymorphisms and haplotypes influence risk for prostate cancer. Prostate (2006) 0.86
Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects. Biochem Pharmacol (2003) 0.86
Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis. J Exp Ther Oncol (2005) 0.85
Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome. Clin Transplant (2012) 0.84
Effect of ezetimibe on major atherosclerotic disease events and all-cause mortality. Am J Cardiol (2012) 0.83
Genetic associations in the vitamin D receptor and colorectal cancer in African Americans and Caucasians. PLoS One (2011) 0.83
National Cancer Institute Prostate Cancer Genetics Workshop. Cancer Res (2011) 0.82
Racial disparities in lipid control in patients with diabetes. Am J Manag Care (2012) 0.82
Iron overload in allogeneic hematopoietic stem cell transplant recipients. Arch Pathol Lab Med (2012) 0.82
Fine-mapping of IL16 gene and prostate cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev (2012) 0.81
Vaccination with leukemia-loaded dendritic cells eradicates residual disease and prevent relapse. J Exp Ther Oncol (2006) 0.81
SPARC affects glioma cell growth differently when grown on brain ECM proteins in vitro under standard versus reduced-serum stress conditions. Neuro Oncol (2003) 0.81
EphB2 SNPs and sporadic prostate cancer risk in African American men. PLoS One (2011) 0.81
Epigenetic modulation of signal transduction pathways in HPV-associated HNSCC. Otolaryngol Head Neck Surg (2013) 0.81
Y chromosome lineages in men of west African descent. PLoS One (2012) 0.80